Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 28
Phase 32

Trial Status

Completed11
Other2

Role Distribution

Principal Investigator12
Other Roles1
PI Rate92%

Activity Timeline

Clinical Trials (13)

NCT04870970Active Not Recruiting
The Effect of Tobacco Products on Wound Healing
SmokingTobacco SmokingTobacco Use
PrincipalinvestigatorStart date: 2021-05-18
NCT03272685Phase 3Completed
Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace
Nicotine DependenceTobacco Smoking
PrincipalinvestigatorStart date: 2018-06-01
NCT01067599Not ApplicableCompleted
Novel Determinants and Measures of Smokeless Tobacco Use: Study 2
Nicotine DependenceTobacco Use Disorder
PrincipalinvestigatorStart date: 2012-03-01
NCT00218283Phase 2Completed
Nicotine Lozenge to Reduce Smokeless Tobacco Use
Tobacco Use Disorder
Principalinvestigator
NCT00218296Phase 2Completed
Comparison Across Treatment Conditions to Reduce Smokeless Tobacco Use
Tobacco Use Disorder
Principalinvestigator
NCT00469079Phase 2Completed
Health Effects of SLT, Cigarette Smoking, and New Tobacco Products
Nicotine Dependence
Principalinvestigator

Showing 10 of 13 trials

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Stephen Hecht, PhD

Department of Laboratory Medicine and Pathology, University of Minnesota

Related
1 trials

Shared therapeutic areas:

Healthy

Worked with same sponsors:

Masonic Cancer Center, University of MinnesotaNational Cancer Institute (NCI)
Collaborated on 1 trial
Similarity Score14%

Jon Ebbet, MD

Mayo Clinic

Related
1 trials

Shared therapeutic areas:

Smoking

Worked with same sponsors:

Mayo ClinicNational Cancer Institute (NCI)+1 more
Collaborated on 1 trial
Similarity Score14%

Christelle Haziza, PhD

Philip Morris Products S.A.

Related
27 trials

Shared therapeutic areas:

SmokingTobacco Use
Similarity Score8%

Elliot Stein, Ph.D.

National Institute on Drug Abuse (NIDA)

Related
20 trials

Shared therapeutic areas:

Nicotine DependenceTobacco Use Disorder

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score8%

Ronald G Crystal, MD

Weill Medical College of Cornell University

Related
21 trials

Shared therapeutic areas:

SmokingHealthy

Worked with same sponsors:

National Cancer Institute (NCI)National Institute on Drug Abuse (NIDA)
Similarity Score8%

emilie garrido pradalie

APHM

Related
35 trials

Shared therapeutic areas:

Healthy
Similarity Score4%

Waqar ahmed awan, Phd

Riphah International University

Related
20 trials

Shared therapeutic areas:

Healthy
Similarity Score4%

Ali MA Ismail, lecturer

Cairo University

Related
27 trials

Shared therapeutic areas:

Tobacco Smoking
Similarity Score4%

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

Healthy
Similarity Score4%

Murad Alam, MD

Northwestern University

Related
65 trials

Shared therapeutic areas:

Healthy
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (13)

Showing 13 of 13 trials

NCT04870970PrincipalInvestigator

The Effect of Tobacco Products on Wound Healing

SmokingTobacco SmokingTobacco Use
Active Not Recruiting
NCT03978117Phase 2PrincipalInvestigator

Clinical Trial of Two Study Drinks in Detoxification of Environmental Toxicants and Carcinogens

Healthy
Completed
NCT03272685Phase 3PrincipalInvestigator

Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace

Nicotine DependenceTobacco Smoking
Completed
NCT01067599Not ApplicablePrincipalInvestigator

Novel Determinants and Measures of Smokeless Tobacco Use: Study 2

Nicotine DependenceTobacco Use Disorder
Completed
NCT00218244Phase 1/2PrincipalInvestigator

Using Smokeless Tobacco Products With Lower Nicotine Levels to Reduce Negative Effects of Smokeless Tobacco Use

Tobacco Use Disorder
Completed
NCT00218270Phase 2PrincipalInvestigator

Effectiveness of Using Tobacco Free Snuff in Reducing Negative Effects of Smokeless Tobacco Use

Tobacco Use Disorder
Completed
NCT00218283Phase 2PrincipalInvestigator

Nicotine Lozenge to Reduce Smokeless Tobacco Use

Tobacco Use Disorder
Completed
NCT00218296Phase 2PrincipalInvestigator

Comparison Across Treatment Conditions to Reduce Smokeless Tobacco Use

Tobacco Use Disorder
Completed
NCT00469079Phase 2PrincipalInvestigator

Health Effects of SLT, Cigarette Smoking, and New Tobacco Products

Nicotine Dependence
Completed
NCT00935818Phase 2/3StudyDirector

Varenicline and Bupropion for Smoking Cessation

Smoking
Completed
NCT01050569Phase 2PrincipalInvestigator

Innovative Interventions for Smoking Cessation

Tobacco Use Disorder
Completed
NCT01067586PrincipalInvestigator

Novel Determinants and Measures of Smokeless Tobacco Use: Study 1

Smokeless Tobacco UseTobacco Dependence
Completed
NCT03352635PrincipalInvestigator

Mechanisms of Ethnic/Racial Differences in Lung Cancer Due to Cigarette Smoking Clinical and Biomarkers Core

Tobacco Use
Withdrawn

All 13 trials loaded